Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial.
暂无分享,去创建一个
P. Serruys | B. Meier | M. Morice | A. Colombo | G. Guagliumi | C. Tamburino | E. Sousa | H. Stoll
[1] J. Nawarskas,et al. Paclitaxel-eluting stents in coronary artery disease. , 2005, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[2] Kurt Ulm,et al. Sirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease: meta-analysis of randomized trials. , 2005, JAMA.
[3] Marco Valgimigli,et al. The unrestricted use of paclitaxel- versus sirolimus-eluting stents for coronary artery disease in an unselected population: one-year results of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry. , 2005, Journal of the American College of Cardiology.
[4] P. Serruys,et al. Maintenance of Long-Term Clinical Benefit With Sirolimus-Eluting Coronary Stents: Three-Year Results of the RAVEL Trial , 2005, Circulation.
[5] G. Breithardt,et al. Relationship of Late Loss in Lumen Diameter to Coronary Restenosis in Sirolimus-Eluting Stents , 2005, Circulation.
[6] J. Stauffer,et al. A prospective randomized comparison between paclitaxel and sirolimus stents in the real world of interventional cardiology: the TAXi trial. , 2005, Journal of the American College of Cardiology.
[7] A. Kastrati,et al. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. , 2005, JAMA.
[8] Gregg W Stone,et al. One-Year Clinical Results With the Slow-Release, Polymer-Based, Paclitaxel-Eluting TAXUS Stent: The TAXUS-IV Trial , 2004, Circulation.
[9] J. Popma,et al. The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). , 2004, Journal of the American College of Cardiology.
[10] G. Stone,et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. , 2004, The New England journal of medicine.
[11] A. Kastrati,et al. Impact of lesion complexity on the capacity of a trial to detect differences in stent performance: results from the ISAR-STEREO trial. , 2003, American heart journal.
[12] William Wijns,et al. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS) , 2003, The Lancet.
[13] Jeffrey W Moses,et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. , 2003, The New England journal of medicine.
[14] S. Silber,et al. Randomized Study to Assess the Effectiveness of Slow- and Moderate-Release Polymer-Based Paclitaxel-Eluting Stents for Coronary Artery Lesions , 2003, Circulation.
[15] Mary E. Russell,et al. TAXUS I: Six- and Twelve-Month Results From a Randomized, Double-Blind Trial on a Slow-Release Paclitaxel-Eluting Stent for De Novo Coronary Lesions , 2003, Circulation.
[16] Patrick W. Serruys,et al. A randomized comparison of a sirolimus eluting stent with a standard stent for coronary revascularization , 2002 .
[17] P. Serruys,et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. , 2002, The New England journal of medicine.
[18] E. Edelman,et al. Stent-versus-stent equivalency trials : are some stents more equal than others? , 1999, Circulation.
[19] 石井 康宏,et al. (119)定量的冠動脈造影(quantitative coronary angiography, QCA)の経時的再現性に関する検討(学位論文内容の要旨および審査の結果の要旨第36集) , 1997 .
[20] G. Mancini,et al. Quantitative coronary angiography , 1994 .
[21] E. Braunwald,et al. Unstable angina. A classification. , 1989, Circulation.
[22] L. Campeau. Letter: Grading of angina pectoris. , 1976, Circulation.
[23] B. Gersh. Sirolimus-Eluting Stent or Paclitaxel-Eluting Stent vs Balloon Angioplasty for Prevention of Recurrences in Patients With Coronary In-Stent Restenosis: A Randomized Controlled Trial , 2006 .
[24] B. Gersh. Incidence, Predictors, and Outcome of Thrombosis After Successful Implantation of Drug-Eluting Stents , 2006 .
[25] Chen Ji-ya. ISAR-DIABETES: Paclitaxel-Eluting Stent Versus Sirolimus-Eluting Stent for the Prevention of Restenosis in Diabetic Patients with Coronary Artery Disease , 2006 .
[26] E. Perin. Choosing a drug-eluting stent: a comparison between CYPHER and TAXUS. , 2005, Reviews in cardiovascular medicine.
[27] J. Moses,et al. Sirolimus-eluting stents vs. standard stents in patients with stenosis in a native coronary artery , 2004 .
[28] P. Serruys,et al. Quantitative Coronary Angiography in Clinical Practice , 1994, Developments in Cardiovascular Medicine.